Loading…
Beta 2-Microglobulin and the Severity of Coronary Stenosis in Patients With Acute Coronary Syndrome
Previous studies have shown that beta 2-microglobulin (B2M) could predict all-cause mortality and cardiovascular mortality in various groups of people. However, the relationship between B2M and severity of coronary stenosis in patients with acute coronary syndrome has not been established. We enroll...
Saved in:
Published in: | Heart, lung & circulation lung & circulation, 2019-04, Vol.28 (4), p.575-582 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Previous studies have shown that beta 2-microglobulin (B2M) could predict all-cause mortality and cardiovascular mortality in various groups of people. However, the relationship between B2M and severity of coronary stenosis in patients with acute coronary syndrome has not been established.
We enrolled 872 consecutive patients admitted with acute coronary syndrome in our study. All participants underwent coronary angiography examination or stent implantation after admission. The severity of coronary stenosis was assessed by Gensini score and the presentation of triple-vessel disease. B2M and other biochemical parameters were measured. All subjects were divided into quartiles of B2M. Multivariate linear regression and logistic regression were applied in the analysis.
Gensini score and the prevalence of triple-vessel disease were elevated in accordance with increasing B2M quartiles (p=0.002 and p0.05 for both).
Our data indicated that B2M was an independent risk factor of coronary stenosis in patients with acute coronary syndrome. |
---|---|
ISSN: | 1443-9506 1444-2892 |
DOI: | 10.1016/j.hlc.2018.02.016 |